Page last updated: 2024-11-08

rac 109

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

RAC 109: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID167664
CHEMBL ID339249
MeSH IDM0170800

Synonyms (20)

Synonym
rac 109
spiro(naphthalene-1(2h),3'-pyrrole)-2',5'-dione, 1',3,4,4'-tetrahydro-1'-(3-(diethylamino)propyl)-, monohydrochloride
spiro(naphthalene-1(2h),3'-pyrrolidine)-2',5'-dione, 3,4-dihydro-1'-(3-(diethylamino)propyl)-, (+)-
rac 109i
spiro(naphthalene-1(2h),3'-pyrrolidine)-2',5'-dione, 3,4-dihydro-1'-(3-(diethylamino)propyl)-, (-)-
rac-109
rac 109ii
brn 1549046
n-(gamma-diethylaminopropyl)-1,2,3,4-tetrahydronaphthalene-1-spirosuccinimide hydrochloride
1'-(3-(diethylamino)propyl)-3,4-dihydrospiro(naphthalene-1(2h),3'-pyrrolidine)-2',5'-dione
28510-14-7
CHEMBL339249 ,
1'-[3-(diethylamino)propyl]spiro[2,3-dihydro-1h-naphthalene-4,3'-pyrrolidine]-2',5'-dione
28309-55-9
17592-97-1
1'-(3-(diethylamino)propyl)-3,4-dihydro-2h-spiro[naphthalene-1,3'-pyrrolidine]-2',5'-dione
1'-[3-(diethylamino)propyl]-3,4-dihydro-2h-spiro[naphthalene-1,3'-pyrrolidine]-2',5'-dione
DTXSID70938720
bdbm50225479
AKOS040747346
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID110154Percentage toxicity measured as convulsions.1981Journal of medicinal chemistry, Jan, Volume: 24, Issue:1
New antiarrhythmic agents. 4. 1'-(Aminoalkyl)-1,2,3,4-tetrahydronaphthalene-1-spiro-3'-pyrrolidine-2',5'-dione derivatives.
AID110241Percentage toxicity measured as ataxia.1981Journal of medicinal chemistry, Jan, Volume: 24, Issue:1
New antiarrhythmic agents. 4. 1'-(Aminoalkyl)-1,2,3,4-tetrahydronaphthalene-1-spiro-3'-pyrrolidine-2',5'-dione derivatives.
AID114333Ataxia was measured in mice after sc administration at given dose1981Journal of medicinal chemistry, Jan, Volume: 24, Issue:1
New antiarrhythmic agents. 4. 1'-(Aminoalkyl)-1,2,3,4-tetrahydronaphthalene-1-spiro-3'-pyrrolidine-2',5'-dione derivatives.
AID115266Percentage toxicity measured as loss of righting reflex.1981Journal of medicinal chemistry, Jan, Volume: 24, Issue:1
New antiarrhythmic agents. 4. 1'-(Aminoalkyl)-1,2,3,4-tetrahydronaphthalene-1-spiro-3'-pyrrolidine-2',5'-dione derivatives.
AID205267Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex1985Journal of medicinal chemistry, Mar, Volume: 28, Issue:3
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
AID114212Protection against chloroform induced arrhythmias was measured in mice after sc administration at given dose1981Journal of medicinal chemistry, Jan, Volume: 24, Issue:1
New antiarrhythmic agents. 4. 1'-(Aminoalkyl)-1,2,3,4-tetrahydronaphthalene-1-spiro-3'-pyrrolidine-2',5'-dione derivatives.
AID111310Percentage toxicity measured as death of mice.1981Journal of medicinal chemistry, Jan, Volume: 24, Issue:1
New antiarrhythmic agents. 4. 1'-(Aminoalkyl)-1,2,3,4-tetrahydronaphthalene-1-spiro-3'-pyrrolidine-2',5'-dione derivatives.
AID205268Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex at 10 uM1985Journal of medicinal chemistry, Mar, Volume: 28, Issue:3
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
AID119034Protection against chloroform induced arrhythmias in mice after subcutaneous administration at 100 mg/kg dose.1981Journal of medicinal chemistry, Jan, Volume: 24, Issue:1
New antiarrhythmic agents. 4. 1'-(Aminoalkyl)-1,2,3,4-tetrahydronaphthalene-1-spiro-3'-pyrrolidine-2',5'-dione derivatives.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (42.86)18.7374
1990's3 (42.86)18.2507
2000's0 (0.00)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.83

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.83 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.83)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]